BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19327247)

  • 1. Simultaneous pulmonary involvement, histologically proven, of sarcoidosis and rheumatoid arthritis.
    Leo G; Iuliano A; Spina D; Bellisai F; Fioravanti A; Galeazzi M
    Clin Exp Rheumatol; 2009; 27(1):164. PubMed ID: 19327247
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of histologically proven rheumatoid arthritis with pulmonary sarcoidosis.
    Menard O; Petit N; Gillet P; Gaucher A; Martinet Y
    Eur Respir J; 1995 Mar; 8(3):472-3. PubMed ID: 7789498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
    Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
    Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
    Nagashima T; Minota S
    J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of refractory rheumatoid arthritis-associated leg ulcerations with adalimumab.
    Hirche D; Rubbert A; Lunau L; Krieg T; Eming SA
    Br J Dermatol; 2005 May; 152(5):1062-4. PubMed ID: 15888173
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.
    Richez C; Blanco P; Gin H; Schaeverbeke T
    Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient.
    Josse S; Klemmer N; Moreno-Swirc S; Goëb V; Lequerré T; Vittecoq O
    Joint Bone Spine; 2009 Dec; 76(6):718-9. PubMed ID: 19464223
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.
    Burns AM; Green PJ; Pasternak S
    J Cutan Pathol; 2012 Feb; 39(2):289-93. PubMed ID: 21899592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of adalimumab for treating rheumatoid arthritis with autoimmune sensorineural hearing loss: two birds with one stone.
    Morovic Vergles J; Radic M; Kovacic J; Salamon L
    J Rheumatol; 2010 May; 37(5):1080-1. PubMed ID: 20439536
    [No Abstract]   [Full Text] [Related]  

  • 12. Sarcoidosis and tocilizumab: is there a link?
    Bustamente L; Buscot M; Marquette CH; Roux C
    Clin Exp Rheumatol; 2017; 35(4):716. PubMed ID: 28516883
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.
    Immonen K; Kauppi M; Hakala M
    Scand J Rheumatol; 2011 May; 40(3):236-8. PubMed ID: 21231814
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of adalimumab in treatment of autoimmune sensorineural hearing loss: a word of caution.
    Conway R; Khan S; Foley-Nolan D
    J Rheumatol; 2011 Jan; 38(1):176; author reply 176. PubMed ID: 21196585
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adalimumab slows the progression of rheumatoid arthritis].
    Pharm Unserer Zeit; 2003; 32(1):75-6. PubMed ID: 12577764
    [No Abstract]   [Full Text] [Related]  

  • 16. Adalimumab for rheumatoid arthritis?
    Ebell M; Kripke C
    Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adalimumab in advanced and early rheumatoid arthritis].
    Szekanecz Z
    Orv Hetil; 2009 Jul; 150(28):1333-4. PubMed ID: 19581162
    [No Abstract]   [Full Text] [Related]  

  • 18. Adalimumab therapy in rheumatoid arthritis.
    Keystone E; Haraoui B
    Rheum Dis Clin North Am; 2004 May; 30(2):349-64, vii. PubMed ID: 15172045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases.
    Erre GL; Mesina P; Tonelli N; Passiu G
    Clin Exp Rheumatol; 2010; 28(4):590-1. PubMed ID: 20659417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of rheumatoid arthritis with adalimumab. Results from a Cochrane review].
    Pedersen SJ; Hetland ML; Østergaard M
    Ugeskr Laeger; 2006 Aug; 168(35):2899-903. PubMed ID: 16982019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.